Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Switching from escitalopram to duloxetine improved hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Clofazimine effectively treated ashy dermatosis in a patient.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

The non-cross-linked hyaluronic acid compound effectively and safely improves keratosis pilaris.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

Biologics for severe asthma have known side effects, but some new risks need more study.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Dupilumab can cause psoriasis in some patients.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

The HG3 hair gel is the most effective for treating seborrheic dermatitis.

Dupilumab for eczema may cause hair loss.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.